Streetbeat News

Equity Actions

ALLR

Allarity Therapeutics Inc (NASDAQ:ALLR) announced the pricing of a public offering of 2.44 million shares and common warrants at a combined price of $4.50 per share, expecting to raise approximately $11 million. The proceeds will be used to pay account payables, accrued liabilities, payments under certain license agreements, an outstanding promissory note, conduct clinical trials, and for working capital. The offering is expected to close on July 10. Following the announcement, Allarity shares were down 52% at $3.96.

Portfolio Pulse from Adam Eckert

July 06, 2023 | 12:52 pm

BABA

BIDU

BILI

FXI

JD

MCHI

Alibaba and other Chinese stocks are trading lower due to signs of a slowdown in mainland China. A selloff in Chinese banks deepened after Goldman Sachs downgraded top Chinese lenders. The Yuan weakened to a seven-month low. Chinese stocks, including Alibaba, Baidu, JD.Com, and Bilibili were down between 1%-3%. Chinese ETFs, including IShares MSCI China ETF and IShares China Large-Cap ETF, were trading lower by 2%.

Portfolio Pulse from Anusuya Lahiri

July 06, 2023 | 12:51 pm

MULN

Mullen Automotive Inc (NASDAQ:MULN) shares are trading higher after the company announced the retention of a law group to investigate possible naked short selling and a buyback of up to $25 million worth of its common stock. The company believes it may have been the target of a market manipulation scheme involving illegal naked short selling.

Portfolio Pulse from Adam Eckert

July 06, 2023 | 12:50 pm

EBIX

Ebix Inc. is progressing with its plan to complete an IPO of its EbixCash subsidiary in India. The company is also in advanced stages of a part-asset sale exercise, with potential proceeds sufficient to repay 100% of its bank debt. The asset sale is intended to be a liability-free transaction for the successful bidder. Ebix has received bids from a mix of strategic and financial bidders.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 12:44 pm

SYT

SYLA Technologies has authorized a $1.385 million ADS buyback program. This move is expected to boost investor confidence and potentially increase the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 12:32 pm

CRIS

Curis has announced a $15.1 million registered direct offering, leading to a decrease in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 12:29 pm

CYTO

Altamira Therapeutics has announced the pricing of a $5 million public offering, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 12:27 pm

CRBU

PFE

Caribou Biosciences has announced a $25 million equity investment from Pfizer, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 12:26 pm

GM

GOOGL

INDA

SLG

On CNBC's 'Halftime Report Final Trades', several investment experts shared their stock picks. Joseph Terranova of Virtus Investment Partners recommended iShares MSCI India ETF (CBOE: INDA) for geographical diversification. Jenny Harrington of Gilman Hill Asset Management suggested SL Green Realty Corp. (NYSE:SLG) which recently sold a 49.9% stake in 245 Park Avenue. Stephen Weiss of Short Hills Capital Partners and Piper Sandler analyst Thomas Champion both favored Alphabet Inc. (NASDAQ:GOOGL). Jim Lebenthal of Cerity Partners picked General Motors Company (NYSE:GM) which unveiled its Ultium Home vehicle-to-home (V2H) hardware.

Portfolio Pulse from Lisa Levin

July 06, 2023 | 12:20 pm

CRBU

GENI

KZIA

Kazia Therapeutics' Paxalisib has received fast-track designation from the FDA for treatment of solid tumor brain metastases, leading to a 39% increase in KZIA's stock. Caribou Biosciences received a $25 million equity investment from Pfizer, resulting in a 22% increase in CRBU's stock. The NFL extended its strategic partnership with Genius Sports, causing a 26% increase in GENI's stock.

Portfolio Pulse from ryanfaloona@benzinga.com

July 06, 2023 | 12:18 pm